{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:55:46Z","timestamp":1781297746876,"version":"3.54.1"},"reference-count":27,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"6","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>\n                      Constitutional epimutations arise early in development and are present across normal tissues, including peripheral blood. Constitutional\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation has emerged as a risk factor for\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      -associated cancers, such as ovarian cancer (OC), and may serve as a biomarker for OC risk. This study retrospectively evaluated the clinical relevance of constitutional\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation in 473 patients with OC enrolled in the observational AGO-TR1 study (ClinicalTrials.gov identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02222883\">NCT02222883<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation was quantified by the methylation-specific real-time polymerase chain reaction using whole blood-derived DNA from 476 female controls and 473 patients with OC along with 473 corresponding tumor-derived DNA samples. Methylation levels \u22651.0% were considered methylation-positive.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation in blood-derived DNA was detected in 42 of 473 patients with OC and in 26 of 476 controls (8.9%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      5.5%; odds ratio [OR], 1.69 [95% CI, 1.02 to 2.80],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0432), with the strongest association observed with methylation levels \u226510% (OR, 6.17 [95% CI, 1.37 to 27.72],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .018). Patients with\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation in blood-derived DNA were diagnosed at a younger median age than those without (54.0\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      60.0 years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .018). Constitutional\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation was less frequent in patients carrying pathogenic germline variants in OC predisposition genes than in noncarriers (4.1%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      10.5%; OR, 0.37 [95% CI, 0.14 to 0.96],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .04) and showed no association with a family history of cancer or platinum-based chemotherapy before blood draw.\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation in blood-derived DNA was correlated with tumor\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Tumor\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation was observed in 64 of 473 samples (13.5%), half (32 of 64) of which were attributable to constitutional\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation also detectable in the blood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      Constitutional\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      promoter methylation accounts for a substantial proportion of OCs and represents a robust biomarker for individual OC risk.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-25-01230","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:59:19Z","timestamp":1781294359000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Constitutional\n                    <i>BRCA1<\/i>\n                    Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study"],"prefix":"10.1200","volume":"10","author":[{"given":"Mohamad","family":"Kayali","sequence":"first","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Institute for Hereditary Cancers, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1152-8367","authenticated-orcid":true,"given":"Eric","family":"Hahnen","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Institute for Hereditary Cancers, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-366X","authenticated-orcid":true,"given":"Alexander","family":"Burges","sequence":"additional","affiliation":[{"name":"Department of Gynecology, University Hospital Munich-Gro\u00dfhadern, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8804-4122","authenticated-orcid":true,"given":"Alexander","family":"Reuss","sequence":"additional","affiliation":[{"name":"Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1751-1638","authenticated-orcid":true,"given":"Julia","family":"Caro-Valenzuela","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Institute for Hereditary Cancers, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"de Gregorio","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Klinikum am Gesundbrunnen, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-0352","authenticated-orcid":true,"given":"Florian","family":"Heitz","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Institute for Hereditary Cancers, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6591-3367","authenticated-orcid":true,"given":"Frederik","family":"Marm\u00e9","sequence":"additional","affiliation":[{"name":"Department of Gynecology, University Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-9577","authenticated-orcid":true,"given":"Felix","family":"Hilpert","sequence":"additional","affiliation":[{"name":"Department of Gynecology, University of Kiel, Kiel, Germany"},{"name":"Onkologisches Therapiezentrum, Krankenhaus Jerusalem, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-577X","authenticated-orcid":true,"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[{"name":"Department of Carl-Gustav-Carus University, Technische Universit\u00e4t Dresden and National Cancer Center (NCT Dresden), Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[{"name":"Department of Women's Health, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Prieske","sequence":"additional","affiliation":[{"name":"Onkologisches Therapiezentrum, Krankenhaus Jerusalem, Hamburg, Germany"},{"name":"Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7247-282X","authenticated-orcid":true,"given":"Christoph","family":"Engel","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany"},{"name":"LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Buderath","sequence":"additional","affiliation":[{"name":"Department of Gynecology, University of Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-7927","authenticated-orcid":true,"given":"Dimo","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Schmutzler","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Institute for Hereditary Cancers, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-6623","authenticated-orcid":true,"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecological Oncology, Charit\u00e9, Campus Virchow, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Institute for Hereditary Cancers, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-5005","authenticated-orcid":true,"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8236-4075","authenticated-orcid":true,"given":"Jan","family":"Hauke","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Institute for Hereditary Cancers, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2021-107904"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01907"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-019-0596-9"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.8545"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186043"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00987-7"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2018-105930"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1673"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.4161\/epi.22561"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05564-z"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.3846"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.15698\/cst2019.04.183"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0529-5"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1983-z"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-270-0_17"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7481-8_32"},{"key":"e_1_3_8_19_2","volume-title":"MedCalc Software","unstructured":"MedCalc Software. https:\/\/www.medcalc.org\/calc\/odds_ratio.php"},{"key":"e_1_3_8_20_2","volume-title":"DATAtab Online Statistics Calculator","author":"numiqo","unstructured":"numiqo: DATAtab Online Statistics Calculator. https:\/\/datatab.de"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2018-105930"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0101"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","unstructured":"L\u00f8nning PE Nikolaienko O Knappskog S: Constitutional epimutations: From rare events toward major cancer risk factors? JCO Precis Oncol 10.1200\/PO-24-00746","DOI":"10.1200\/PO-24-00746"},{"key":"e_1_3_8_24_2","first-page":"5329","article-title":"BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study","volume":"60","author":"Baldwin RL","year":"2000","unstructured":"Baldwin RL, Nemeth E, Tran H, et al: BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study. Cancer Res 60:5329-5333, 2000","journal-title":"Cancer Res"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep04026"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.1.61"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249708"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.07.002"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-01230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:59:25Z","timestamp":1781294365000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-01230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1200\/PO-25-01230"],"URL":"https:\/\/doi.org\/10.1200\/po-25-01230","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2025-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2501230"}}